SCM
PTLA

Silvant Capital Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Silvant Capital Management’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-5,686
Closed -$215K – 351
2018
Q2 		$215K Hold
5,686
– – 0.03% 190
2018
Q1 		$186K Buy
+5,686
New +$186K 0.02% 206